entertainment -WSS

entertainment

author：knowledge 2025-09-07 13:58:12 - browse：33684

Elf Bar disposable vape flavored vaping e-cigarette products are displayed in a convenience store. — The FDA is ramping up its efforts to force vape shops and other retailers to stop selling Elf Bar and Esco Bar products. PATRICK T. FALLON/AFP via Getty Images

WASHINGTON — The Food and Drug Administration is ramping up its efforts to force vape shops and other retailers to stop selling unauthorized disposable vape brands that are increasingly popular with young people.

The FDA recently issued 189 formal warning letters to shops selling two brands of vape products, Elf Bar and Esco Bars, the agency announced in a press release Thursday. The FDA has not authorized either brand, both of which are ubiquitous in gas stations and smoke shops around the country. They are therefore illegal to sell.

“This latest blitz should be a wake-up call for retailers of Elf Bar and Esco Bars products nationwide,” said Brian King, the head of the FDA’s tobacco center in a statement announcing the blitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Oral obesity drug from Viking Therapeutics hits key early target

focus

WSS

Resistance to opioid

Harvard scientists, with Google, unveil the most detailed brain map ever

Ebola vaccine can save some who are already sick, per new study

Doctors on social media are being harassed and cyberbullied

Multiple sclerosis has subtypes with different best treatments: study

Researchers test human milk's ability to repair gut microbiome

entertainment

entertainment

focus

Tori Bowie and the unacceptable rates of Black maternal death

Long Covid research funding gets a major boost from NIH

Hepatitis C has a cure — but many Americans still lack access to it

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

How one medical school became remarkably diverse

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Alkermes shareholders re

Researchers test human milk's ability to repair gut microbiome

Cancer drug shortages should be causing more outrage

Young boy dies in trial for Pfizer Duchenne gene therapy

explore

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Artificial intelligence use in health care faces greater scrutiny in 2024

Abbott's new heart device gets FDA advisory panel nod

Study: Black kids more likely to die after surgery than white kids

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Juul documents reveal insider tactics on political lobbying

focus

focus

focus

Wikipedia